Articles, App Notes, Case Studies, & White Papers

31. RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It Matters 2/25/2026

    Explore why RTSM should be viewed as a system for managing change. Learn how platform-based reusability reduces UAT churn, preserves institutional memory, and stabilizes mid-study amendments.

32. Flexible Integrations To Reduce Risks And Increase Efficiencies 10/4/2024

    Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.

33. Study, Not Software: Aligning RTSM To The Protocol 10/21/2024

    How can RTSM platforms improve your clinical trial and how do they integrate with your crucial trial systems?

34. Mid-Study RTSM Migration: How To Switch Vendors Without Disrupting Your Trial 3/9/2026

    Evaluate the risks of staying with an underperforming RTSM provider versus the benefits of a mid-study transition. Modern migration tools now offer a secure path to protect trial data and timelines.

35. Rethinking RTSM Software: When Bigger Isn't Better 3/9/2026

    Don’t let legacy vendor inertia jeopardize your trial. Discover why agility and deep RTSM expertise are the new benchmarks for reducing risk and ensuring precision in clinical operations.

36. Gain Confidence In Clinical Trial Outcomes

    Delve into the ways that smart packaging integrations within clinical trial strategies can improve adherence to dosing protocols and provide a comprehensive understanding of a patient’s exposure.

37. Providing Drug Supply Support In Complex Environments Through IRT 4/5/2023

    Learn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.

38. 24/7 Cell & Gene Control Tower Provides Agile Solution For Critical Shipments 3/1/2023

    Get an overview of a successful re-route of six critical shipments to the UK and Spain from Amsterdam used to deliver CAR-T drug products to treat non-Hodgkin’s lymphoma cancer patients.

39. Planning For The Return And Destruction Of Your Product 8/24/2022

    Aspects of accountability, reconciliation, return, and destruction require significant effort to compile historical data. A little up-front planning can remove many future complications.

40. Benefits Of Electronic Labels: Investigational Medicinal Products 12/2/2022

    When a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.